Inhibitors of platelet aggregation. 3. ((Dialkylamino)alkyl)thio heterocyclic compounds.
D000166:Acridines / Q000138:chemical synthesis / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000818:Animals; D005343:Fibrinolytic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D006571:Heterocyclic Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D009287:Naphthyridines / Q000138:chemical synthesis / Q000494:pharmacology; D010618:Phenanthrolines / Q000138:chemical synthesis / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011799:Quinazolines / Q000138:chemical synthesis / Q000494:pharmacology; D011804:Quinolines / Q000138:chemical synthesis / Q000494:pharmacology; D011817:Rabbits; D013438:Sulfhydryl Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D014966:Xanthenes / Q000138:chemical synthesis / Q000494:pharmacology
D000166:Acridines; D005343:Fibrinolytic Agents; D006571:Heterocyclic Compounds; D009287:Naphthyridines; D010618:Phenanthrolines; D011799:Quinazolines; D011804:Quinolines; D013438:Sulfhydryl Compounds; D014966:Xanthenes; D000244:Adenosine Diphosphate